DE60323936D1 - Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung - Google Patents

Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung

Info

Publication number
DE60323936D1
DE60323936D1 DE60323936T DE60323936T DE60323936D1 DE 60323936 D1 DE60323936 D1 DE 60323936D1 DE 60323936 T DE60323936 T DE 60323936T DE 60323936 T DE60323936 T DE 60323936T DE 60323936 D1 DE60323936 D1 DE 60323936D1
Authority
DE
Germany
Prior art keywords
chiral
polyketals
methods
biodegradable biocompatible
polyketal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60323936T
Other languages
English (en)
Inventor
Mikhail I Papisov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Application granted granted Critical
Publication of DE60323936D1 publication Critical patent/DE60323936D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G16/00—Condensation polymers of aldehydes or ketones with monomers not provided for in the groups C08G4/00 - C08G14/00
    • C08G16/02—Condensation polymers of aldehydes or ketones with monomers not provided for in the groups C08G4/00 - C08G14/00 of aldehydes
    • C08G16/04—Chemically modified polycondensates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G4/00—Condensation polymers of aldehydes or ketones with polyalcohols; Addition polymers of heterocyclic oxygen compounds containing in the ring at least once the grouping —O—C—O—
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L59/00—Compositions of polyacetals; Compositions of derivatives of polyacetals
    • C08L59/02—Polyacetals containing polyoxymethylene sequences only

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Biological Depolymerization Polymers (AREA)
DE60323936T 2002-01-14 2003-01-14 Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung Expired - Lifetime DE60323936D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34833302P 2002-01-14 2002-01-14
PCT/US2003/001017 WO2003059988A2 (en) 2002-01-14 2003-01-14 Biodegradable polyketal polymers and methods for their formation and use

Publications (1)

Publication Number Publication Date
DE60323936D1 true DE60323936D1 (de) 2008-11-20

Family

ID=23367539

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60323936T Expired - Lifetime DE60323936D1 (de) 2002-01-14 2003-01-14 Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung

Country Status (6)

Country Link
US (3) US7838619B2 (de)
EP (1) EP1468036B1 (de)
AT (1) ATE410459T1 (de)
AU (1) AU2003209227A1 (de)
DE (1) DE60323936D1 (de)
WO (1) WO2003059988A2 (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4698843B2 (ja) * 1999-05-17 2011-06-08 エーザイ インコーポレイテッド 生体活性剤の改良された細胞取り込み
US8106098B2 (en) * 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
DE60323936D1 (de) 2002-01-14 2008-11-20 Gen Hospital Corp Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung
EP1585817B1 (de) * 2002-02-20 2009-09-02 The General Hospital Corporation Konjugate mit biologisch abbaubarem polymer und verwendung dafür
CA2492803C (en) 2002-07-19 2013-11-05 The General Hospital Corporation Oxime conjugates and methods for their formation and use
NZ538405A (en) * 2002-08-01 2007-12-21 Aesgen Inc Improved treatment of cancer with glutamine and carbohydrate
US7790150B2 (en) * 2003-09-05 2010-09-07 The General Hospital Corporation Dual phase drug release system
JP2008540558A (ja) * 2005-05-10 2008-11-20 エモリー・ユニバーシティ ミセルおよび粒子を用いた、活性物質の送達のための新規の戦略
MY166613A (en) * 2005-11-22 2018-07-17 Gfbiochemicals Ltd Glycerol levulinate ketals and their use
WO2007098041A1 (en) 2006-02-17 2007-08-30 Medtronic, Inc. Polyketal polymers, and methods of making and using same
US7850382B2 (en) * 2007-01-18 2010-12-14 Sanford, L.P. Valve made from two materials and writing utensil with retractable tip incorporating same
US7488130B2 (en) * 2007-02-01 2009-02-10 Sanford, L.P. Seal assembly for retractable instrument
US20090004243A1 (en) 2007-06-29 2009-01-01 Pacetti Stephen D Biodegradable triblock copolymers for implantable devices
WO2009032905A1 (en) 2007-09-04 2009-03-12 Segetis, Inc. Ketal compounds from polyols and oxocarboxylates
MX2010005857A (es) * 2007-11-28 2010-11-22 Mersana Therapeutics Inc Conjugados de analogos de fumagillina biodegradables biocompatibles.
US8226312B2 (en) * 2008-03-28 2012-07-24 Sanford, L.P. Valve door having a force directing component and retractable instruments comprising same
US8653223B2 (en) * 2008-04-16 2014-02-18 Segetis, Inc. Transketalized compositions, synthesis, and applications
WO2010017075A1 (en) * 2008-08-07 2010-02-11 Sigma-Aldrich Co. Preparation of low molecular weight polylysine and polyornithine in high yield
EP2367811A1 (de) 2008-09-25 2011-09-28 Segetis, Inc. Ketalesterderivate
US8221012B2 (en) * 2008-11-07 2012-07-17 Sanford, L.P. Retractable instruments comprising a one-piece valve door actuating assembly
PA8853201A1 (es) 2008-12-10 2010-07-27 Mersana Therapeutics Inc Formulaciones farmaceuticas de conjugados de camtotecina-polimero biocompatibles biodegradables
US8393814B2 (en) 2009-01-30 2013-03-12 Sanford, L.P. Retractable instrument having a two stage protraction/retraction sequence
KR101808867B1 (ko) 2009-06-22 2018-01-18 세게티스, 인코포레이티드. 케탈 화합물 및 이의 용도
WO2011038117A2 (en) 2009-09-23 2011-03-31 The Regents Of The University Of California Chemically amplified response strategies for medical sciences
WO2011041487A1 (en) 2009-09-30 2011-04-07 Innovotech, Llc Biocompatible and biodegradable polymers from renewable natural polyphenols
JP2013528665A (ja) 2010-03-26 2013-07-11 メルサナ セラピューティックス， インコーポレイテッド ポリヌクレオチドの送達のための修飾ポリマー、その製造方法、およびその使用方法
CA2792018A1 (en) 2010-05-10 2011-11-17 Segetis, Inc. Fragrant formulations, methods of manufacture thereof and articles comprising the same
US9074065B2 (en) 2010-08-12 2015-07-07 Segetis, Inc. Latex coating compositions including carboxy ester ketal coalescents, methods of manufacture, and uses thereof
US8828917B2 (en) 2010-08-12 2014-09-09 Segetis, Inc. Carboxy ester ketal removal compositions, methods of manufacture, and uses thereof
CN103097604A (zh) 2010-09-13 2013-05-08 赛格提斯有限公司 织物软化剂组合物及其制造方法
US8758778B2 (en) 2010-09-16 2014-06-24 The Regents Of The University Of California Polymeric nano-carriers with a linear dual response mechanism and uses thereof
KR20130131323A (ko) 2010-10-18 2013-12-03 세게티스, 인코포레이티드. 카복시 에스터 케탈을 포함하는 수희석성 코팅 조성물, 그리고 그의 제조방법 및 용도
US8507718B2 (en) 2010-11-11 2013-08-13 Segetis, Inc. Ketocarboxylic acids, methods of manufacture and uses thereof
US9212176B2 (en) 2010-11-11 2015-12-15 Segetis, Inc. Polyketal adducts, methods of manufacture and uses thereof
BR112013010073A2 (pt) 2010-11-11 2016-07-05 Segetis Inc adutos de éster polihidróxi cetálico, métodos de fabricação e seus usos
US8728453B2 (en) 2011-02-28 2014-05-20 Innovotech, Llc Combinatorial polymeric compositions for drug delivery
EP3228325A1 (de) 2011-06-10 2017-10-11 Mersana Therapeutics, Inc. Protein-polymer-wirkstoffkonjugate
WO2013037708A1 (en) * 2011-09-16 2013-03-21 Ferring B.V. A fast dissolving pharmaceutical composition
CN104768538A (zh) 2012-08-28 2015-07-08 加利福尼亚大学董事会 具有光触发释放机制的聚合物纳米载体
US9458414B2 (en) 2012-09-21 2016-10-04 Gfbiochemicals Limited Cleaning, surfactant, and personal care compositions
US9156809B2 (en) 2012-11-29 2015-10-13 Segetis, Inc. Carboxy ester ketals, methods of manufacture, and uses thereof
CA2892863C (en) 2012-12-10 2022-03-15 Mersana Therapeutics, Inc. Polymeric scaffold based on phf for targeted drug delivery
US10226535B2 (en) 2012-12-10 2019-03-12 Mersana Therapeutics, Inc. Auristatin compounds and conjugates thereof
KR102505172B1 (ko) 2013-09-19 2023-02-28 마이크로벤션, 인코포레이티드 중합체 필름
CA2923753C (en) 2013-09-19 2021-10-12 Terumo Corporation Polymer particles
JP6427564B2 (ja) 2013-10-11 2018-11-21 アサナ・バイオサイエンシズ，リミテッド・ライアビリティ・カンパニー タンパク質−ポリマー−薬物共役体
EP3054991B1 (de) 2013-10-11 2019-04-03 Mersana Therapeutics, Inc. Protein-polymer-wirkstoffkonjugate
US9688788B2 (en) 2013-11-08 2017-06-27 Terumo Corporation Polymer particles
CA2931547A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
WO2015179572A1 (en) 2014-05-20 2015-11-26 The Regents Of The University Of California Layerless bioprinting via dynamic optical projection and uses thereof
TWI695011B (zh) 2014-06-18 2020-06-01 美商梅爾莎納醫療公司 抗ｈｅｒ２表位之單株抗體及其使用之方法
US9919058B2 (en) 2014-07-15 2018-03-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Polyketal particles including a CpG oligodeoxynucleotide for the treatment of lung cancer
US11324827B2 (en) 2014-10-01 2022-05-10 Xiamen Sinopeg Biotech Co., Ltd. Multifunctionalized polyethylene glycol derivative and preparation method therefor
CN104877127B (zh) 2015-06-23 2017-11-10 厦门赛诺邦格生物科技股份有限公司 一种八臂聚乙二醇衍生物、制备方法及其修饰的生物相关物质
WO2016154592A1 (en) 2015-03-26 2016-09-29 Microvention, Inc. Embiolic particles
EP4302782A3 (de) 2016-03-15 2024-03-27 Mersana Therapeutics, Inc. Gegen napi2b gerichtete antikörper-wirkstoff-konjugate und verfahren zur verwendung davon
US11071714B2 (en) 2016-04-29 2021-07-27 Children's Medical Center Corporation Poly(ketals) and related compositions and methods
JP6548843B1 (ja) * 2016-06-03 2019-07-24 ノバサイト インコーポレイテッド ポリマーリンカーおよびそれらの使用法
KR102162370B1 (ko) 2016-09-28 2020-10-06 테루모 가부시키가이샤 중합체 입자
WO2018160538A1 (en) 2017-02-28 2018-09-07 Mersana Therapeutics, Inc. Combination therapies of her2-targeted antibody-drug conjugates
CN111315414A (zh) 2017-06-22 2020-06-19 梅尔莎纳医疗公司 产生载药聚合物支架和蛋白-聚合物-药物缀合物的方法
WO2019204392A1 (en) * 2018-04-17 2019-10-24 Purdue Research Foundation Modifying surface of a live cell and the uses thereof
CN111545148B (zh) * 2020-04-07 2022-06-07 华东交通大学 一种手性催化方法及其催化装置
US11833742B2 (en) 2020-06-26 2023-12-05 The Regents Of The University Of California High-fidelity 3D printing using flashing photopolymerization
CN116102002A (zh) * 2021-11-09 2023-05-12 闽都创新实验室 一种金属-有机框架限域的手性碳纳米点及其制备方法和应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE744162A (fr) 1969-01-16 1970-06-15 Fuji Photo Film Co Ltd Procede d'encapsulage
DE2718254C3 (de) 1977-04-25 1980-04-10 Hoechst Ag, 6000 Frankfurt Strahlungsempfindliche Kopiermasse
US4389330A (en) 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
US4374953A (en) 1982-04-19 1983-02-22 Dow Corning Corporation Method for preparing polyacetals and polyketals by emulsion polymerization
US4882397A (en) 1986-12-05 1989-11-21 Amoco Corporation Method for converting polyketals to polyaryletherketones in the presence of a metal salt
US4793986A (en) * 1987-02-25 1988-12-27 Johnson Matthey, Inc. Macromolecular platinum antitumor compounds
JPH01190636A (ja) 1988-01-22 1989-07-31 Green Cross Corp:The 制癌作用物質複合体
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6610841B1 (en) 1997-12-18 2003-08-26 Gilead Sciences, Inc. Nucleotide-based prodrugs
AU4778893A (en) 1992-07-21 1994-02-14 General Hospital Corporation, The System of drug delivery to the lymphatic tissues
US5624803A (en) 1993-10-14 1997-04-29 The Regents Of The University Of California In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom
US5612037A (en) 1994-07-26 1997-03-18 Connaught Laboratories, Inc. Influenza virus subunit conjugates
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US6048837A (en) 1994-08-17 2000-04-11 The Rockefeller University OB polypeptides as modulators of body weight
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
WO1996030386A1 (fr) 1995-03-31 1996-10-03 Drug Delivery System Institute, Ltd. Derives d'amidite et derives d'oligonucleotides
US5574127A (en) 1995-04-05 1996-11-12 Aqualon Hydrophobically modified poly(acetal-polyethers)
US5811510A (en) 1995-04-14 1998-09-22 General Hospital Corporation Biodegradable polyacetal polymers and methods for their formation and use
AU6028396A (en) 1995-06-07 1996-12-30 Amgen, Inc. Ob protein compositions and method
PL189698B1 (pl) 1996-03-12 2005-09-30 Pg Txl Co Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania
US5817343A (en) 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
US5935599A (en) 1996-10-28 1999-08-10 The Board Of Trustees Of The University Of Illinois Polymer-associated liposomes for drug delivery and method of manufacturing the same
GB9623051D0 (en) 1996-11-06 1997-01-08 Schacht Etienne H Delivery of DNA to target cells in biological systems
US6042820A (en) 1996-12-20 2000-03-28 Connaught Laboratories Limited Biodegradable copolymer containing α-hydroxy acid and α-amino acid units
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US5830730A (en) 1997-05-08 1998-11-03 The Regents Of The University Of California Enhanced adenovirus-assisted transfection composition and method
IL146795A0 (en) 1999-06-18 2002-07-25 Ml Lab Plc Biologically active materials
IL131074A0 (en) 1999-07-23 2001-03-19 Polygene Ltd A biodegradable polycation composition for delivery of an anionic macromolecule
US6822086B1 (en) 1999-08-09 2004-11-23 The General Hospital Corporation Drug-carrier complexes and methods of use thereof
EP1206285A2 (de) 1999-08-09 2002-05-22 The General Hospital Corporation Arzneimittelträger komplexe und ihre verfahren und anwendung
US8106098B2 (en) 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
WO2002020663A2 (en) 2000-09-06 2002-03-14 Ap Pharma, Inc. Degradable polyacetal polymers
DE60323936D1 (de) * 2002-01-14 2008-11-20 Gen Hospital Corp Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung
EP1585817B1 (de) 2002-02-20 2009-09-02 The General Hospital Corporation Konjugate mit biologisch abbaubarem polymer und verwendung dafür
CA2492803C (en) 2002-07-19 2013-11-05 The General Hospital Corporation Oxime conjugates and methods for their formation and use
WO2004009774A2 (en) 2002-07-19 2004-01-29 Amgen Inc. Protein conjugates with a water-soluble biocompatible, biogradable polymer
MX367615B (es) 2002-09-06 2019-08-28 Cerulean Pharma Inc Polimeros a base de ciclodextrina para el suministro de agentes terapeuticos.
US7790150B2 (en) 2003-09-05 2010-09-07 The General Hospital Corporation Dual phase drug release system

Also Published As

Publication number Publication date
US7838619B2 (en) 2010-11-23
US20060069230A1 (en) 2006-03-30
EP1468036B1 (de) 2008-10-08
WO2003059988A3 (en) 2003-12-18
ATE410459T1 (de) 2008-10-15
US20100150832A1 (en) 2010-06-17
US8383758B2 (en) 2013-02-26
AU2003209227A1 (en) 2003-07-30
US20110275700A1 (en) 2011-11-10
WO2003059988A2 (en) 2003-07-24
US7951898B2 (en) 2011-05-31
EP1468036A2 (de) 2004-10-20

Similar Documents

Publication Publication Date Title
DE60323936D1 (de) Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung
DE50111495D1 (de) Künstliche sauerstoffträger aus vernetztem modifizierten human- oder schweinehämoglobin, verfahren zu ihrer herstellung aus gereinigtem material, sowie deren verwendung
DE60312333D1 (de) Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
BRPI0413728B8 (pt) muteína da lipocalina da lágrima humana, métodos para geração e para produção de muteína, composição farmacêutica e uso de muteína
ATE485304T1 (de) Muteine von tearlipocalin und verfahren zu deren gewinnung
TR200401029T4 (tr) Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
SI1284716T1 (sl) Samoemulzirajoäśi aktivni snovni sestavek in uporaba tega sestavka
DE69933518D1 (de) Stabile flüssige zusammensetzungen von kalzium-ascorbat und verfahren zu ihrer herstellung und verwendung
DE60040190D1 (de) Hydrogel zusammensetzungen, geeignet zur verzögerten freisetzung von makromolekülen sowie verfahren zur herstellung derselben.
ATE314350T1 (de) Malonsäure derivate, verfahren zu ihrer herstellung, ihre verwendung als inhibitor der faktor xa aktivität und pharmazeutische zusammensetzungen diese enthaltend
ATE349412T1 (de) Epothilon-synthesebausteine i: unsymmetrisch substituierte acyloine und acyloinderivate, verfahren zu deren herstellung sowie deren verwendung zur herstellung von epothilonen und epothilonderivaten
DE50000866D1 (de) Verfahren zur herstellung von festen cyclodextrinhaltigen dosierungsformen
AR018357A1 (es) Acido petroselinico en una composicion y en un metodo para reducir o eliminar la irritacion o la picazon de la piel inducida por los alfa-hidroxiacidos
ATE405292T1 (de) Injektierbare wässrige paclitaxel-lösungen und verfahren zu ihrer herstellung
DE602004025344D1 (de) Biologisch abbaubare verzweigte polylactidderivate, die zur bildung von polymermicellen befähigt sind, herstellungsverfahren dafür und verwendung davon
BRPI0401103A (pt) Composição compósita, método para formar a mesma, composição modificada, e, método para formar a mesma
ATE461226T1 (de) Verfahren zur herstellung von polyacrolein
DE60202203D1 (de) Neues verfahren zur herstellung von oxabispidinen
ATE302175T1 (de) Verfahren zur herstellung von (18f) radiomarkierten nitroimidazol-derivaten zum nachweis zellulärer hypoxie
DE502007003888D1 (de) Feste oder wässrige alkalische zubereitung umfassend eine kreatin-komponente, verfahren zu deren herstellung und ihre verwendung
ATE193297T1 (de) Wasserlösliche derivate epipodophyllotoxine, verfahren zu ihrer herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
ATE296274T1 (de) Verfahren zur herstellung von verbindungen mit einer cf2o-brücke
ATE440831T1 (de) Verfahren zur herstellung von ungesättigten lactonen
ATE513841T1 (de) Neue thioxyloseverbindungen, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und deren verwendung in therapeutika
ATE259784T1 (de) Propanolaminotetraline, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition